Senate Bill 334 would repeal North Carolina’s Drug Tax by eliminating Article 2D of Subchapter I of Chapter 105 of the General Statutes. The bill is straightforward and does not create a new tax or regulatory program; instead, it removes the existing statutory framework that imposes a tax on controlled substances.
The bill also includes a savings clause preserving rights, liabilities, refunds, and credits that arose before the repeal takes effect. In other words, any tax obligations, disputes, or refund claims tied to the Drug Tax before enactment would remain governed by the prior law, while future enforcement under that article would end once the act becomes law.
Impact
If enacted, the bill would remove the North Carolina Drug Tax from state law by repealing the statute that authorizes it. This would affect the Department of Revenue’s ability to assess and collect the tax on controlled substances going forward, while preserving preexisting liabilities and refund rights for past periods. The repeal would also eliminate the associated statutory basis for taxing illegal drugs under Chapter 105.
Sentiment
There is no recorded committee debate or vote history in the provided materials, so the bill’s sentiment cannot be measured from transcripts or roll calls. Based on the bill text alone, it appears to be a targeted repeal measure with a clear and limited policy objective. The absence of recorded opposition or support in the provided context leaves the overall legislative sentiment indeterminate.
Contention
No specific points of contention are documented in the provided committee transcripts or votes. In general, a repeal of the Drug Tax could raise questions about state revenue, enforcement policy, and whether the tax serves as a deterrent or merely creates administrative burdens, but none of those issues are reflected in the supplied legislative history. The bill’s sponsors are Senators Mayfield and Meyer, and no opposing viewpoints are included in the record provided.